These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 20099745

  • 1. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
    Tkácová M, Vertaková-Krakovská B, Belohorská B, Miskovská V, Helpianska L, Ondrus D, Ondrusová M, Spánik S, Svec J.
    Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
    Alberts DS, Marth C, Alvarez RD, Johnson G, Bidzinski M, Kardatzke DR, Bradford WZ, Loutit J, Kirn DH, Clouser MC, Markman M, GRACES Clinical Trial Consortium.
    Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
    [Abstract] [Full Text] [Related]

  • 9. [Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer].
    Plaisant N, Quenet F, Fabbro M, Gourgou S, Gutowski M, Saint-Aubert B, Rouanet P.
    Gynecol Obstet Fertil; 2004 May; 32(5):391-7. PubMed ID: 15177208
    [Abstract] [Full Text] [Related]

  • 10. Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
    De Placido S, Scambia G, Di Vagno G, Naglieri E, Lombardi AV, Biamonte R, Marinaccio M, Cartenì G, Manzione L, Febbraro A, De Matteis A, Gasparini G, Valerio MR, Danese S, Perrone F, Lauria R, De Laurentiis M, Greggi S, Gallo C, Pignata S.
    J Clin Oncol; 2004 Jul 01; 22(13):2635-42. PubMed ID: 15226331
    [Abstract] [Full Text] [Related]

  • 11. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Jul 01; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P, Lehmann N, Kimmig R, Burges A, Meier W, Du Bois A, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Gynecol Oncol; 2007 Jul 01; 106(1):69-74. PubMed ID: 17397910
    [Abstract] [Full Text] [Related]

  • 13. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 01; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 14. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
    Hatae M, Onishi Y, Nakamura T, Yamamoto H, Kusumoto M, Matsui T, Mihara K, Taniguchi H.
    Gan To Kagaku Ryoho; 2001 Nov 01; 28(12):1833-7. PubMed ID: 11729475
    [Abstract] [Full Text] [Related]

  • 15. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I, Szánthó A, Mayer A, Thurzó L, Pulay T.
    Orv Hetil; 2003 May 11; 144(19):919-24. PubMed ID: 12809068
    [Abstract] [Full Text] [Related]

  • 16. Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.
    Capizzi E, Gabusi E, Grigioni AD, De Iaco P, Rosati M, Zamagni C, Fiorentino M.
    Diagn Mol Pathol; 2008 Mar 11; 17(1):34-8. PubMed ID: 18303408
    [Abstract] [Full Text] [Related]

  • 17. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M, Zetterqvist BM, Dahllöf K, Brännström M, Horvath G.
    Acta Obstet Gynecol Scand; 2008 Mar 11; 87(12):1343-52. PubMed ID: 18951208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P.
    Gynecol Oncol; 1998 Dec 11; 71(3):431-6. PubMed ID: 9887245
    [Abstract] [Full Text] [Related]

  • 20. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.
    Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, Lhommé C, Duvillard P, Castaigne D.
    J Am Coll Surg; 2003 Dec 11; 197(6):955-63. PubMed ID: 14644284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.